Quest Diagnostics Q1 revenue $2.37B (+1.5% YoY); raises full-year adjusted EPS to $8.72-$8.97

QUEST DIAGNOSTICS INC

2024-Q1 EPS reported $1.72 revenue$2,366,000,000

Revenue $2.366B, up 1.5% YoY; base business revenue grew nearly 6%.
Reported diluted EPS $1.72 (down 3.4%); adjusted diluted EPS $2.04 (flat YoY).
Full-year 2024 guidance raised: revenue $9.40B-$9.48B, adjusted EPS $8.72-$8.97.
Invigorate initiative driving productivity; growth in brain, women's, and cardiometabolic health.
Cash from operations $154M (+64.8%); capex $104M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

QUEST DIAGNOSTICS INC reported the quarter ended March 31, 2024 results: revenue $2,366, net income $194, EPS $1.72. Guidance raised.

Period: the quarter ended March 31, 2024
Revenue: $2,366
Net income: $194
EPS: $1.72
Guidance: raised
Result: reported results

Exact text from the filing

adjusted earnings guidance for the full year," Mr. Davis said. Three Months Ended March 31, 2024 2023 Change (dollars in millions, except per share data) Reported: Net revenues $ 2,366 $ 2,331 1.5 % Diagnostic Information Services revenues $ 2,298 $ 2,259 1.7 % Revenue per requisition 0.1 % Requisition volume 1.6 % Organic requisition volume 1.0 % Operating

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

QUEST DIAGNOSTICS INC filing history →

Source: SEC EDGAR

accession 0001022079-24-000096

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.